- £7.67m
- £0.41m
- £1.18m
- 45
- 24
- 13
- 15
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.67 | ||
| Price to Tang. Book | 1.03 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.42 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -31.05% | ||
| Return on Equity | -31.79% | ||
| Operating Margin | -296.94% | ||
Financial Summary
| Year End 31st May | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 0.45 | 0.29 | 0.59 | 1.02 | 1.18 | 1.85 | 5.99 | 15.98% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Feedback plc is a United Kingdom-based clinical infrastructure specialist. The Company designs products that enhance clinician access to patient data and to their colleagues. The Company's approach centers around individual patient episodes, into which it pulls relevant clinical data from hospital systems and around which it builds remote clinical teams for collaboration. Its products include Bleepa and CareLocker. Bleepa is its application layer and sits on top of CareLocker as its data layer. Bleepa is a clinician facing platform that displays clinical results from a patient's CareLocker at a certified and regulated quality, that is suitable for clinical use and enables dialogue on a patient-by-patient basis with colleagues through a secure, auditable chat interface that links back to the patient medical record. The CareLocker data storage model is built around the patient. The Company has a number of growth opportunities domestically and internationally across a range of markets.
Directors
- Rory Shaw NEC
- Thomas Oakley CEO (33)
- Aneshkumar Patel CFO (40)
- Adam Denning NID
- Timothy Irish NID
- Philipp Prince NID (55)
- Last Annual
- May 31st, 2024
- Last Interim
- November 30th, 2024
- Incorporated
- February 11th, 1958
- Public Since
- January 8th, 1986
- No. of Employees
- 26
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
London Stock Exchange- Shares in Issue
- 43,814,779
- Address
- 201 Temple Chambers, 3-7 Temple Avenue, LONDON, EC4Y 0DT
- Web
- https://feedbackmedical.com/investors/
- Phone
- +44 2039977634
- Auditors
- Price Bailey LLP
Latest News for FDBK
Upcoming Events for FDBK
Full Year 2025 Feedback PLC Earnings Release
Similar to FDBK
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Angle
London Stock Exchange
Aoti
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 20:35 UTC, shares in Feedback are trading at 17.50p. This share price information is delayed by 15 minutes.
Shares in Feedback last closed at 17.50p and the price had moved by -82.05% over the past 365 days. In terms of relative price strength the Feedback share price has underperformed the FTSE All Share Index by -82.54% over the past year.
The overall consensus recommendation for Feedback is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreFeedback does not currently pay a dividend.
Feedback does not currently pay a dividend.
Feedback does not currently pay a dividend.
To buy shares in Feedback you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 17.50p, shares in Feedback had a market capitalisation of £7.67m.
Here are the trading details for Feedback:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: FDBK
Based on an overall assessment of its quality, value and momentum Feedback is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Feedback is 60.00p. That is 242.86% above the last closing price of 17.50p.
Analysts covering Feedback currently have a consensus Earnings Per Share (EPS) forecast of -£0.22 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Feedback. Over the past six months, its share price has underperformed the FTSE All Share Index by -69.18%.
As of the last closing price of 17.50p, shares in Feedback were trading -45.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Feedback PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 17.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Feedback's management team is headed by:
- Rory Shaw - NEC
- Thomas Oakley - CEO
- Aneshkumar Patel - CFO
- Adam Denning - NID
- Timothy Irish - NID
- Philipp Prince - NID